Table 1 Patient Characteristics and baseline variables stratified by datasets
Variables | Training (n = 599) | Validation (n = 244) | P Value |
|---|---|---|---|
Age, years | 69 (66, 72) | 69 (66, 73) | 0.36 |
Sex (Male), n (%) | 385 (64.3) | 168 (68.9) | 0.23 |
BMI, kg·m− 2 | 23.6 (21.6, 25.7) | 23.5 (20.9, 26.0) | 0.68 |
Hypertension, n (%) | 230 (38.4) | 89 (36.5) | 0.64 |
Diabetes, n (%) | 109 (18.2) | 48 (19.7) | 0.63 |
Cardiovascular diseases, n (%) | 80 (13.4) | 43 (17.6) | 0.13 |
CKD, n (%) | 26 (4.3) | 6 (2.5) | 0.24 |
Pulmonary diseases, n (%) | 32 (5.3) | 12 (4.8) | 0.87 |
Hepatitis/ cirrhosis, n (%) | 125 (20.9) | 49 (20.1) | 0.85 |
ASA PS, n (%) | Â | Â | 0.77 |
 I-II | 491 (82.0) | 203 (83.2) | |
 III-IV | 108 (18.0) | 41 (16.8) | |
Pathology, n (%) | Â | Â | 0.13 |
 Hepatoma | 383 (63.9) | 154 (63.1) | |
 Cholangiocarcinoma | 82 (13.7) | 46 (18.9) | |
 Hepatic Metastasis | 16 (2.7) | 8 (3.3) | |
 Benign | 118 (19.7) | 36 (14.8) | |
Hemoglobin, g·L− 1 | 131 (120, 142) | 130 (119, 140) | 0.34 |
Albumin, g·L− 1 | 39.0 (36.1, 41.6) | 39.0 (36.8, 41.4) | 0.71 |
Total bilirubin, μmol·L−1 | 13.1 (9.2, 19.6) | 12.6 (9.7, 19.7) | 1.00 |
Direct bilirubin, μmol·L−1 | 4.3 (3.0, 7.5) | 4.3 (3.0, 7.7) | 0.90 |
Fasting blood glucose, μmol·L−1 | 5.04 (4.58, 5.83) | 5.12 (4.62, 5.96) | 0.51 |
Creatinine, μmol·L−1 | 68.4 (59.0, 79.2) | 66.1 (58.5, 76.8) | 0.29 |
eGFR, ml·min·1.73 m−2 | 89.8 (80.8, 94.4) | 90.1 (84.5, 95.2) | 0.11 |